awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53752984-85AD4EA5-C215-4EA4-B8DC-EB1F34160890
Q53752984-85AD4EA5-C215-4EA4-B8DC-EB1F34160890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53752984-85AD4EA5-C215-4EA4-B8DC-EB1F34160890
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).
P2860
Q53752984-85AD4EA5-C215-4EA4-B8DC-EB1F34160890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53752984-85AD4EA5-C215-4EA4-B8DC-EB1F34160890
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
595b8192aaac8cd673a4c5668aa9c7dd1128c23f
P2860
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.